Log in
Enquire now
‌

Iasis Molecular Sciences INC. SBIR Phase I Award, September 2021

A SBIR Phase I contract was awarded to Iasis Molecular Sciences, Inc. in September, 2021 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention.

OverviewStructured DataIssuesContributors

Contents

AbstractTimelineTable: Further ResourcesReferences
sbir.gov/node/2159699
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
Iasis Molecular Sciences, Inc.
Iasis Molecular Sciences, Inc.
1
Government Agency
Loading...
1
Government Branch
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
1
Award Type
SBIR1
Contract Number (US Government)
1R43CK000621-011
Award Phase
Phase I1
Award Amount (USD)
225,0001
Date Awarded
September 1, 2021
1
End Date
August 31, 2022
1
Abstract

ABSTRACT: Health care-associated infections (HAIs) are all too common in today’s clinics. More than 1.7 million ca es of transmission occur annually and often the implicated infectious organisms are transferred from inanimate objects capable of sustaining their viability. The disinfection methods that are used routinely in hospitals today are imperfect. The available and accepted methods for minimizing patient-to-patient transmission include: 1. improved cleaning and disinfection of room surfaces, 2. implementation of 'no touch' methods for terminal room disinfection, e.g. ultraviolet light or hydrogen peroxide, and 3. use of 'self-disinfecting' surfaces to reduce the surface bioburden. Current 'self-disinfecting' clinical surfaces with the antibacterial label are limited to those fabricated from copper metal and painted surfaces incorporating quaternary ammonium compounds (QACs). In the proposed effort, antimicrobial composite paints and composite epoxy flooring incorporating novel copper additives are formulated and evaluated for effectiveness against bacteria, viruses, and fungi. The major elements of the specific aims of the proposed research involves: 1. The synthesis and characterization of ion exchange biocides, formulation into coating substrat s, and 2.The evaluation of the time-dependent biological performance of the modified composites.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Iasis Molecular Sciences INC. SBIR Phase I Award, September 2021

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.